UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events

Circulation (New York, N.Y.), 2000-09, Vol.102 (13), p.1503-1510

2000

Volltextzugriff (PDF)

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM

Diabetes care, 1998-04, Vol.21 (4), p.597-603

1998

Volltextzugriff (PDF)

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Circulation (New York, N.Y.), 2002-05, Vol.105 (20), p.2341-2346

2002

Volltextzugriff (PDF)

Reduction of stroke events with pravastatin : The Prospective Pravastatin Pooling (PPP) Project

Circulation (New York, N.Y.), 2001-01, Vol.103 (3), p.387-392

2001

Volltextzugriff (PDF)

Reduction in cardiovascular events during pravastatin therapy : pooled analysis of clinical events of the pravastatin atherosclerosis intervention program

Circulation (New York, N.Y.), 1995-11, Vol.92 (9), p.2419-2425

1995

Volltextzugriff (PDF)

Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy

Arteriosclerosis, thrombosis, and vascular biology, 2002-10, Vol.22 (10), p.1692-1697

2002

Volltextzugriff (PDF)

Results of the primary outcome measure and clinical events from the asymptomatic carotid artery progression study

The American journal of cardiology, 1995-09, Vol.76 (9), p.47C-53C

1995

Volltextzugriff (PDF)

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data

Atherosclerosis, 1998-05, Vol.138 (1), p.11-24

1998

Volltextzugriff (PDF)

Pravastatin, lipids, and major coronary events

The American journal of cardiology, 1994-06, Vol.73 (15), p.1133-1134

1994

Volltextzugriff (PDF)

Isradipine in prediabetic hypertensive subjects

Diabetes care, 1998-12, Vol.21 (12), p.2103-2110

1998

Volltextzugriff (PDF)

Reduction in coronary events during treatment with pravastatin

The American journal of cardiology, 1995-09, Vol.76 (9), p.60C-63C

1995

Volltextzugriff (PDF)

Biologic determinants of propranolol disposition: Results from 1308 patients in the beta-blocker heart attack trial

Clinical pharmacology and therapeutics, 1985-11, Vol.38 (5), p.509-518

1985

Volltextzugriff (PDF)

Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events

The Lancet (British edition), 1997-10, Vol.350 (9084), p.1075-1076

1997

Volltextzugriff (PDF)

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses

Archives of internal medicine (1960), 2004-01, Vol.164 (1), p.40

2004

Volltextzugriff (PDF)

Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial

JAMA : the journal of the American Medical Association, 1985-03, Vol.253 (12), p.1733

1985

Volltextzugriff (PDF)

ASSESSMENT OF ANGINA PECTORIS AFTER MYOCARDIAL INFARCTION: COMPARISON OF “ROSE QUESTIONNAIRE” WITH PHYSICIAN JUDGMENT IN THE BETA-BLOCKER HEART ATTACK TRIAL

American journal of epidemiology, 1985-04, Vol.121 (4), p.555-562

1985

Volltextzugriff (PDF)

Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)

The American journal of cardiology, 1997-10, Vol.80 (8), p.1087-1090

1997

Volltextzugriff (PDF)

Multicenter Study with Isradipine and Diuretics Against Atherosclerosis

Journal of cardiovascular pharmacology, 1990, Vol.15 Suppl 1, p.S23-S29

1990

Volltextzugriff (PDF)

Long term propranolol treatment and changes in body weight after myocardial infarction

BMJ, 1990-04, Vol.300 (6729), p.902-903

1990

Volltextzugriff (PDF)

Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS)

The American journal of cardiology, 1995-11, Vol.76 (12), p.899-905

The PPP Project Investigators

1995

Volltextzugriff (PDF)

Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia

Journal of the American College of Cardiology, 1986-01, Vol.7 (1), p.1-8

1986

Volltextzugriff (PDF)

Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: The beta-blocker heart attack trial experience

The American journal of cardiology, 1990-06, Vol.65 (20), p.1287-1291

1990

Volltextzugriff (PDF)

Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction who receive propranolol

The American journal of cardiology, 1988-05, Vol.61 (13), p.975-978

1988

Volltextzugriff (PDF)

Maximizing recruitment efforts in a drug lipid-lowering trial with dietary intervention to lower LDL cholesterol

Controlled clinical trials, 1996-02, Vol.17 (1), p.33-45

1996

Volltextzugriff (PDF)

Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)

The American journal of cardiology, 1995-03, Vol.75 (7), p.455-459

1995

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(27)
Medical Sciences
(27)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(23)
Female
(18)
Male
(18)
Middle Aged
(17)
Cardiovascular System & Cardiology
(16)
Cardiac & Cardiovascular Systems
(15)
Cardiovascular System
(14)
Aged
(12)
Double-Blind Method
(12)
General And Cellular Metabolism. Vitamins
(10)
Follow-Up Studies
(8)
Pravastatin - Therapeutic Use
(8)
Adult
(7)
Anticholesteremic Agents - Therapeutic Use
(7)
Cardiovascular Disease
(7)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Reduction of stroke events with pravastatin : The Prospective Pravastatin Pooling (PPP) Project

Reduction in cardiovascular events during pravastatin therapy : pooled analysis of clinical events of the pravastatin atherosclerosis intervention program

Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy

Results of the primary outcome measure and clinical events from the asymptomatic carotid artery progression study

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data

Pravastatin, lipids, and major coronary events

Isradipine in prediabetic hypertensive subjects

Reduction in coronary events during treatment with pravastatin

Biologic determinants of propranolol disposition: Results from 1308 patients in the beta-blocker heart attack trial

Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses

Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial

ASSESSMENT OF ANGINA PECTORIS AFTER MYOCARDIAL INFARCTION: COMPARISON OF “ROSE QUESTIONNAIRE” WITH PHYSICIAN JUDGMENT IN THE BETA-BLOCKER HEART ATTACK TRIAL

Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)

Multicenter Study with Isradipine and Diuretics Against Atherosclerosis

Long term propranolol treatment and changes in body weight after myocardial infarction

Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia

Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: The beta-blocker heart attack trial experience

Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction who receive propranolol

Maximizing recruitment efforts in a drug lipid-lowering trial with dietary intervention to lower LDL cholesterol

Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)

Aktive Filter

Suchergebnisse filtern